In CRC tissues, the expression levels of PCAT6, miR‐204, and HMGA2 were all dysregulated, indicating that modulating the above regulatory axis may ameliorate the chemoresistance of CRC to 5‐FU‐based chemotherapy. The gene discussed is HMGA2; the disease is colorectal carcinoma.